Compare · LUCY vs RXST
LUCY vs RXST
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- RXST is the larger of the two at $266.2M, about 28.9x LUCY ($9.2M).
- LUCY has been more active in the news (12 items in the past 4 weeks vs 5 for RXST).
- RXST has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Innovative Eyewear Inc.
- RxSight Inc.
- Price
- -
- -
- Market cap
- $9.2M
- $266.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2021
- News (4w)
- 12
- 5
- Recent ratings
- 0
- 25
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest LUCY
- Chief Financial Officer Gayle Oswald was granted 32,466 shares and sold $13,491 worth of shares (15,533 units at $0.87), increasing direct ownership by 591% to 19,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad sold $11,874 worth of shares (13,627 units at $0.87) and was granted 41,800 shares, increasing direct ownership by 220% to 40,977 units (SEC Form 4)
- Chief Operating Officer Abondano Joaquin was granted 29,600 shares and sold $8,414 worth of shares (9,799 units at $0.86), increasing direct ownership by 380% to 25,012 units (SEC Form 4)
- Chief Executive Officer Gross Harrison R. was granted 49,200 shares and sold $24,411 worth of shares (27,738 units at $0.88), increasing direct ownership by 156% to 35,195 units (SEC Form 4)
- Chief Technology Officer Cohen David Eric was granted 36,400 shares and sold $14,587 worth of shares (15,769 units at $0.93), increasing direct ownership by 307% to 27,342 units (SEC Form 4)
- Innovative Eyewear, Inc. Announces Strategic Alliance with HTC Corporation
- Innovative Eyewear Announces Expansion Into More than 150 Stores of One of the Largest Big Box Retailers in the United States
- Innovative Eyewear, Inc. Announces Major New AI and News Features for Lucyd App
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results
Latest RXST
- Amendment: SEC Form SC TO-I/A filed by RxSight Inc.
- SEC Form SC TO-I filed by RxSight Inc.
- SEC Form 10-Q filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- SEC Form 4 filed by President and CEO Mottiwala Aziz
- SEC Form 3 filed by new insider Mottiwala Aziz
- SEC Form S-8 filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Regulation FD Disclosure